102 related articles for article (PubMed ID: 2916444)
21. Plasma human pancreatic polypeptide response in chronic pancreatitis.
Matsumoto M; Wakasugi H; Ibayashi H
Gastroenterol Jpn; 1982; 17(1):25-30. PubMed ID: 7042449
[TBL] [Abstract][Full Text] [Related]
22. Plasma cholecystokinin concentrations in patients with advanced chronic pancreatitis.
Cantor P; Petronijevic L; Worning H
Pancreas; 1986; 1(6):488-93. PubMed ID: 3562443
[TBL] [Abstract][Full Text] [Related]
23. Impaired pancreatic polypeptide release in chronic pancreatitis with steatorrhoea.
Adrian TE; Besterman HS; Mallinson CN; Garalotis C; Bloom SR
Gut; 1979 Feb; 20(2):98-101. PubMed ID: 428832
[TBL] [Abstract][Full Text] [Related]
24. Cholecystokinin secretion in patients with chronic pancreatitis and after different types of pancreatic surgery.
Eddes EH; Masclee AA; Gielkens HA; Verkijk M; Vecht J; Biemond I; Lamers CB
Pancreas; 1999 Aug; 19(2):119-25. PubMed ID: 10438157
[TBL] [Abstract][Full Text] [Related]
25. Effect of cholestyramine on plasma cholecystokinin and pancreatic polypeptide levels, and exocrine pancreatic secretion.
Koop I; Fellgiebel A; Koop H; Schafmayer A; Arnold R
Eur J Clin Invest; 1988 Oct; 18(5):517-23. PubMed ID: 3147905
[TBL] [Abstract][Full Text] [Related]
26. High fat diets increase plasma cholecystokinin and pancreatic polypeptide, and decrease plasma insulin and feed intake in lactating cows.
Choi BR; Palmquist DL
J Nutr; 1996 Nov; 126(11):2913-9. PubMed ID: 8914965
[TBL] [Abstract][Full Text] [Related]
27. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
[TBL] [Abstract][Full Text] [Related]
28. Plasma cholecystokinin and pancreatic polypeptide secretion in response to bombesin, meal ingestion and modified sham feeding in lean and obese persons.
Lieverse RJ; Masclee AA; Jansen JB; Lamers CB
Int J Obes Relat Metab Disord; 1994 Feb; 18(2):123-7. PubMed ID: 8148926
[TBL] [Abstract][Full Text] [Related]
29. Plasma concentrations of neurotensin and CCK in patients with chronic pancreatitis with and without enzyme substitution.
Nustede R; Köhler H; Fölsch UR; Schafmayer A
Pancreas; 1991 May; 6(3):260-5. PubMed ID: 1713670
[TBL] [Abstract][Full Text] [Related]
30. Plasma cholecystokinin and pancreatic polypeptide response after radical pancreatoduodenectomy with Billroth I and Billroth II type of reconstruction.
Inoue K; Tobe T; Suzuki T; Hosotani R; Kogire M; Fuchigami A; Miyashita T; Tsuda K; Seino Y
Ann Surg; 1987 Aug; 206(2):148-54. PubMed ID: 3606240
[TBL] [Abstract][Full Text] [Related]
31. Availability of plasma pancreatic polypeptide measurement in diagnosis of chronic pancreatitis.
Yamamura T; Mori K; Tatsumi M; Kotoura Y; Yoshiya K; Itoh N; Seino Y
Scand J Gastroenterol; 1981; 16(6):757-61. PubMed ID: 7323707
[TBL] [Abstract][Full Text] [Related]
32. High plasma cholecystokinin response following ingestion of test meal by patients with non-insulin dependent diabetes mellitus.
Nakano I; Funakoshi A; Shinozaki H; Miyazaki K; Ibayashi H; Tateishi K; Hamaoka T
Regul Pept; 1986 May; 14(3):229-36. PubMed ID: 3726174
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic polypeptide response in patients with chronic pancreatitis.
Valenzuela JE; Taylor IL; Walsh JH
Dig Dis Sci; 1979 Nov; 24(11):862-4. PubMed ID: 520107
[TBL] [Abstract][Full Text] [Related]
34. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
[TBL] [Abstract][Full Text] [Related]
35. Correlation between exocrine pancreatic secretion and serum concentration of human pancreatic polypeptide in chronic pancreatitis.
Andersen BN; Hagen C; Klein HC; Stadil F; Worning H
Scand J Gastroenterol; 1980; 15(6):699-704. PubMed ID: 7209380
[TBL] [Abstract][Full Text] [Related]
36. Do bile acids exert a negative feedback control of cholecystokinin release?
Koop I; Koop H; Gerhardt C; Schafmayer A; Arnold R
Scand J Gastroenterol; 1989 Apr; 24(3):315-20. PubMed ID: 2734590
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic polypeptide secretion in diabetic patients with idiopathic haemochromatosis.
Lassmann V; Passa P; Vague P; Vialettes B
Diabete Metab; 1987 Apr; 13(2):106-9. PubMed ID: 3595966
[TBL] [Abstract][Full Text] [Related]
38. Decreased plasma levels of cholecystokinin in healthy males after chronic ingestion of a heat-treated soya product.
Lu LJ; Anderson KE; Gomez G; Nealon WH
Cancer Lett; 1995 Apr; 90(2):149-55. PubMed ID: 7736450
[TBL] [Abstract][Full Text] [Related]
39. Antroduodenal motility in chronic pancreatitis: are abnormalities related to exocrine insufficiency?
Vu MK; Vecht J; Eddes EH; Biemond I; Lamers CB; Masclee AA
Am J Physiol Gastrointest Liver Physiol; 2000 Mar; 278(3):G458-66. PubMed ID: 10712266
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man.
Regan PT; Go VL; DiMagno EP
J Lab Clin Med; 1980 Oct; 96(4):743-8. PubMed ID: 7419959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
